骨微环境的调节网络和机制在瘤发生和转移过程中
Guofang Huang1,2, Tianhui Hou1,2, Dianwen Song2
1University of Shanghai for Science and Technology, Shanghai, China.
Journal of bone oncology
|December 16, 2025
概括
骨微环境 (BME) 的失调驱动骨瘤生长和转移. 向BME提供了治疗潜力,但面临着挑战,对健康的骨产生非目标影响.
科学领域:
- 在瘤学瘤学.
- 骨生物学 骨生物学
- 瘤微环境研究 研究
背景情况:
- 骨瘤是由骨微环境 (BME) 的调节失调引起的,影响骨平衡.
- 瘤进展和转移是由BME内部的相互作用驱动的,影响骨质细胞-骨质细胞平衡.
- 疼痛和骨折等临床症状是这些BME与瘤相互作用的结果.
研究的目的:
- 系统地审查骨微环境在骨瘤发作,进展和转移中的作用.
- 探索瘤对细胞,矩阵和信号轴的BME重编程的机制.
- 评估新兴的BME向疗法及其相关的翻译挑战.
主要方法:
- 系统的文献综述综合了关于BME组成和瘤相互作用的研究.
- 对BME在骨瘤转移和治疗耐药性的机制性作用的分析.
- 审查目前和新兴的针对性疗法,专注于BME.
主要成果:
- 通过细胞动力学,矩阵重塑和信号干扰,BME失调促进瘤发生和转移.
- 放射图案反映了BME与瘤的相互作用,特别是骨质细胞与骨质细胞的不平衡.
- 以BME为导向的疗法有前途,但对健康的骨有显著的非目标效应.
结论:
- 骨微环境是骨恶性瘤的关键驱动因素,也是潜在的治疗点.
- 针对BME需要采取策略,尽量减少对骨平衡的不良影响.
- 未来的研究应该专注于针对骨癌的组织特异性微环境向.
更多相关视频
08:24Measuring Bone Remodeling and Recreating the Tumor-Bone Microenvironment Using Calvaria Co-culture and Histomorphometry
Published on: March 14, 2020
7.2K
06:00Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines
Published on: September 13, 2017
7.5K
相关概念视频
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
